Epstein-Barr virus reactivation in a patient treated with anti-thymocyte globulin for severe aplastic anemia.
Am J Hematol
; 81(5): 355-7, 2006 May.
Article
em En
| MEDLINE
| ID: mdl-16628717
ABSTRACT
Epstein-Barr virus (EBV) infection and reactivation is an increasing complication in immune deficient patients, particularly after allogeneic hematopoietic stem cell transplantation (HSCT). Therapy with anti-thymocyte globulin (ATG) is associated with higher incidence of EBV-related disease in HSCT patients, but this risk is not documented in patients receiving ATG for severe aplastic anemia (SAA). We describe the case of a patient who developed an EBV infection, with the clinical features of an infectious mononucleosis, after immune suppression with cyclosporine and two courses of ATG for SAA.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Infecções Oportunistas
/
Infecções por Vírus Epstein-Barr
/
Imunossupressores
/
Anemia Aplástica
/
Soro Antilinfocitário
Limite:
Adult
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2006
Tipo de documento:
Article